we must continue to invest in critical NIH research to help develop cures for cancer, alzheimer/dementia, heart disease and other chronic and acute diseases
Invest in critical NIH research to develop cures for major diseases.
Occurrences
Restoring and expanding federal funding in groundbreaking biomedical research for our research agencies that employ many 6th District residents, as well as the many entrepreneurs and small businesses who build on that foundational research.
Evidence
McClain Delaney said she voted yes on the FY2026 three-bill minibus and highlighted that it "supports lifesaving biomedical research" by increasing NIH funding by more than $400 million, including money for cancer, Alzheimer’s, ALS, diabetes, and women’s health research.
The House Science Committee’s Research and Technology page lists Rep. April McClain Delaney as a Democratic member and shows recent May 2026 activity on research and development legislation, indicating she remains active on federal research policy in the current term.
Assessments
McClain Delaney materially supported the promised NIH investment by voting for FY2026 appropriations legislation that she said increased NIH funding by more than $400 million for major disease research, including cancer, Alzheimer’s, ALS, diabetes, and women’s health. However, the evidence shows her support and House-side advancement rather than a clearly enacted federal funding outcome attributable to her, so this merits partial credit rather than full delivery.